ACE and hydrops fetalis: Compared with non-HF individuals, a greater proportion of HFpEF patients were on an antiplatelet, beta-blocker, diuretic, and angiotensin-converting enzyme inhibitors (ACEI)/angiotensin receptor blockers (ARBs) therapy.